Two Sigma Advisers LP Purchases Shares of 38,800 Alignment Healthcare, Inc. (NASDAQ:ALHC)

Two Sigma Advisers LP purchased a new stake in Alignment Healthcare, Inc. (NASDAQ:ALHC) in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 38,800 shares of the company’s stock, valued at approximately $436,000.

Other large investors also recently made changes to their positions in the company. US Bancorp DE lifted its position in Alignment Healthcare by 6,544.2% in the 4th quarter. US Bancorp DE now owns 98,932 shares of the company’s stock valued at $1,113,000 after acquiring an additional 97,443 shares in the last quarter. Barclays PLC lifted its holdings in shares of Alignment Healthcare by 144.1% in the third quarter. Barclays PLC now owns 193,446 shares of the company’s stock valued at $2,287,000 after purchasing an additional 114,191 shares in the last quarter. Northern Trust Corp boosted its position in shares of Alignment Healthcare by 8.6% during the fourth quarter. Northern Trust Corp now owns 908,964 shares of the company’s stock worth $10,226,000 after buying an additional 72,063 shares during the period. Franklin Resources Inc. bought a new position in shares of Alignment Healthcare during the fourth quarter worth about $732,000. Finally, Proficio Capital Partners LLC acquired a new stake in Alignment Healthcare in the 4th quarter valued at approximately $184,000. Institutional investors own 86.19% of the company’s stock.

Analysts Set New Price Targets

ALHC has been the subject of several research reports. Barclays raised their price target on shares of Alignment Healthcare from $8.00 to $9.00 and gave the stock an “underweight” rating in a research note on Friday, February 28th. Stifel Nicolaus raised their target price on shares of Alignment Healthcare from $18.00 to $23.00 and gave the company a “buy” rating in a research report on Tuesday, April 8th. William Blair reiterated an “outperform” rating on shares of Alignment Healthcare in a research note on Friday, February 28th. Robert W. Baird increased their price objective on shares of Alignment Healthcare from $17.00 to $22.00 and gave the stock an “outperform” rating in a research note on Tuesday, April 15th. Finally, Stephens restated an “overweight” rating and issued a $17.00 price objective on shares of Alignment Healthcare in a report on Monday, February 24th. One analyst has rated the stock with a sell rating, three have assigned a hold rating and seven have issued a buy rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $17.17.

Insider Buying and Selling at Alignment Healthcare

In related news, CEO John E. Kao sold 90,000 shares of the business’s stock in a transaction on Tuesday, March 11th. The stock was sold at an average price of $15.36, for a total value of $1,382,400.00. Following the completion of the sale, the chief executive officer now directly owns 2,093,100 shares in the company, valued at $32,150,016. The trade was a 4.12% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, insider Andreas P. Wagner sold 7,632 shares of the company’s stock in a transaction on Wednesday, March 19th. The shares were sold at an average price of $16.40, for a total value of $125,164.80. Following the completion of the transaction, the insider now directly owns 223,474 shares in the company, valued at approximately $3,664,973.60. This represents a 3.30% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 17,784,649 shares of company stock valued at $273,320,208 in the last quarter. 7.00% of the stock is currently owned by insiders.

Alignment Healthcare Stock Down 0.1%

Shares of ALHC stock opened at $15.32 on Thursday. Alignment Healthcare, Inc. has a 52-week low of $7.05 and a 52-week high of $21.06. The company has a debt-to-equity ratio of 1.82, a quick ratio of 1.60 and a current ratio of 1.60. The stock has a market cap of $3.03 billion, a price-to-earnings ratio of -19.90 and a beta of 1.22. The firm’s 50-day moving average is $16.83 and its 200-day moving average is $14.75.

Alignment Healthcare (NASDAQ:ALHC) last released its quarterly earnings data on Thursday, May 1st. The company reported ($0.05) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.12) by $0.07. Alignment Healthcare had a negative return on equity of 108.69% and a negative net margin of 5.84%. The firm had revenue of $926.93 million for the quarter, compared to analyst estimates of $889.83 million. During the same quarter in the prior year, the company earned ($0.25) earnings per share. The business’s revenue for the quarter was up 47.5% compared to the same quarter last year. Sell-side analysts predict that Alignment Healthcare, Inc. will post -0.69 EPS for the current year.

Alignment Healthcare Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.